Adaptive Design for Staggered-Start Clinical Trial
Adaptive Design for Staggered-Start Clinical Trial
In phase II and/or III clinical trial study, there are several competing treatments, the goal is to assess the performances of the treatments at the end of the study, the trial design aims to minimize risks to the patients in the trial, according to some given allocation optimality criterion. Recently, …